or Try an Advanced Search...

    Technical Analysis for RNLX - Renalytix AI plc

    Grade Last Price % Change Price Change
    F 0.16 -23.32% -0.05
    RNLX closed down 23.32 percent on Friday, November 1, 2024, on 2 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical RNLX trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    New 52 Week Low Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Gapped Down Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Lower Bollinger Band Walk Weakness -23.32%
    Wide Bands Range Expansion -23.32%
    Older End-of-Day Signals for RNLX ...

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    RNLX Chart by TradingView
    Basic chart:

    Profile

    RenalytixAI is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs. Our goal is to lower healthcare costs and improve patient quality of life by transforming the paradigm for kidney disease risk assessment and clinical management through our KidneyIntelX platform.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Artificial Intelligence Medical Technology Health Informatics Kidney Disease In Vitro Quality Of Life Risk Assessment Healthcare Costs In Vitro Diagnostics Artificial Intelligence Applications Artificial Intelligence In Healthcare Clinical Management

    Is RNLX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 8 Commencement of trading on OTCQB in the United States
    Aug 26 Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
    Jul 29 Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Jul 11 Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US
    Jun 27 Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination
    Jun 14 Medicare Issues Final Coverage Determination for kidneyintelX.dkd
    Jun 5 Renalytix files for selling of 26.8M shares by stockholders
    May 15 Renalytix Plc (RNLX) Q3 2024 Earnings Call Transcript
    May 15 Renalytix AI GAAP EPS of -$0.08 beats by $0.01, revenue of $0.54M misses by $0.56M
    May 15 Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
    See more RNLX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.4
    52 Week Low 0.1511
    Average Volume 681,891
    200-Day Moving Average 0.52
    50-Day Moving Average 0.31
    20-Day Moving Average 0.25
    10-Day Moving Average 0.21
    Average True Range 0.03
    RSI (14) 30.56
    ADX 24.94
    +DI 13.28
    -DI 31.44
    Chandelier Exit (Long, 3 ATRs) 0.22
    Chandelier Exit (Short, 3 ATRs) 0.25
    Upper Bollinger Bands 0.34
    Lower Bollinger Band 0.16
    Percent B (%b) -0.02
    BandWidth 69.97
    MACD Line -0.03
    MACD Signal Line -0.03
    MACD Histogram -0.007
    Fundamentals Value
    Market Cap 7.93 Million
    Num Shares 50 Million
    EPS -1.00
    Price-to-Earnings (P/E) Ratio -0.16
    Price-to-Sales 19.69
    Price-to-Book 7.33
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.18
    Resistance 3 (R3) 0.18 0.18 0.18
    Resistance 2 (R2) 0.18 0.17 0.18 0.18
    Resistance 1 (R1) 0.17 0.17 0.16 0.17 0.18
    Pivot Point 0.16 0.16 0.16 0.16 0.16
    Support 1 (S1) 0.15 0.15 0.15 0.15 0.14
    Support 2 (S2) 0.14 0.15 0.14 0.14
    Support 3 (S3) 0.13 0.14 0.14
    Support 4 (S4) 0.13